EG19304A - Method of treating pre-menstrual syndrome - Google Patents

Method of treating pre-menstrual syndrome

Info

Publication number
EG19304A
EG19304A EG1690A EG1690A EG19304A EG 19304 A EG19304 A EG 19304A EG 1690 A EG1690 A EG 1690A EG 1690 A EG1690 A EG 1690A EG 19304 A EG19304 A EG 19304A
Authority
EG
Egypt
Prior art keywords
menstrual syndrome
treating pre
pms
menstrual
syndrome
Prior art date
Application number
EG1690A
Other languages
English (en)
Inventor
Michael Cohen
Original Assignee
Michael Cohen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27154756&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG19304(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Michael Cohen filed Critical Michael Cohen
Application granted granted Critical
Publication of EG19304A publication Critical patent/EG19304A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
EG1690A 1989-01-17 1990-01-14 Method of treating pre-menstrual syndrome EG19304A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/297,328 US4945103A (en) 1989-01-17 1989-01-17 Method of treating pre-menstrual syndrome
PCT/US1990/000154 WO1991012007A1 (en) 1989-01-17 1990-02-09 Method of treating pre-menstrual syndrome
AU51928/90A AU642864B2 (en) 1989-01-17 1990-02-09 Method of treating pre-menstrual syndrome
CA002075904A CA2075904C (en) 1989-01-17 1990-02-09 Method of treating pre-menstrual syndrome

Publications (1)

Publication Number Publication Date
EG19304A true EG19304A (en) 1994-11-30

Family

ID=27154756

Family Applications (1)

Application Number Title Priority Date Filing Date
EG1690A EG19304A (en) 1989-01-17 1990-01-14 Method of treating pre-menstrual syndrome

Country Status (11)

Country Link
US (1) US4945103A (de)
EP (1) EP0514373B1 (de)
KR (1) KR0171408B1 (de)
AT (1) ATE124260T1 (de)
AU (1) AU642864B2 (de)
CA (1) CA2075904C (de)
DE (1) DE69020582T2 (de)
EG (1) EG19304A (de)
ES (1) ES2074565T3 (de)
IL (1) IL93053A (de)
WO (1) WO1991012007A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116828A (en) * 1989-10-26 1992-05-26 Nippon Zoki Pharmaceutical Co., Ltd. Pharmaceutical composition for treatment of osteoporosis
US5707652A (en) * 1990-12-04 1998-01-13 State Of Oregon Methods of treating circadian rhythm phase disorders
US6638963B1 (en) 1990-12-04 2003-10-28 Oregon Health And Science University Methods for treating circadian rhythm disorders
ATE181670T1 (de) * 1991-05-09 1999-07-15 Neurim Pharma 1991 Melatonin enthaltende arzneimittel
PT100973A (pt) * 1991-10-18 1994-06-30 Alza Corp Dispositivo e composicoes farmaceuticas para a administracao de melatonina por via transdermica
DK0565296T3 (da) * 1992-04-07 1996-12-09 Neurim Pharma 1991 Anvendelse af melatonin til fremstilling af et lægemiddel til behandling af godartet prostatahyperplasi
US5385736A (en) * 1993-07-12 1995-01-31 Minnesota Mining And Manufacturing Company Transdermal melatonin delivery system
WO1995003043A1 (en) * 1993-07-26 1995-02-02 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University Sustained release oral compositions containing melatonin
US5688520A (en) * 1995-03-29 1997-11-18 Minnesota Mining And Manufacturing Company Transmucosal delivery of melatonin for prevention of migraine
EP0901376A1 (de) * 1996-05-20 1999-03-17 Fuisz Technologies Ltd. Melatonin in kombination mit analgetika
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US6133453A (en) * 1998-05-15 2000-10-17 Pharm-Eco Laboratories, Inc. Method for making substituted indoles
US20040131579A1 (en) * 1998-09-10 2004-07-08 Avon Products, Inc. Method and compositions for reducing dermatological aging and for reducing bruising
US6479545B1 (en) * 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
DE19957710A1 (de) * 1999-11-30 2001-05-31 Asat Ag Applied Science & Tech Verwendung von Melatonin zur Behandlung der androgenetischen Alopezie
US20020119191A1 (en) * 2000-04-24 2002-08-29 Hitoo Nishino Pharmaceutical or food composition for treatment or prevention of brain edema
JP2005513080A (ja) 2001-12-20 2005-05-12 フェムファーマ， インコーポレイテッド 薬物の膣送達
JP2006515026A (ja) 2003-01-02 2006-05-18 フェムファーマ ホールディング カンパニー， インコーポレイテッド 乳房の疾患および障害の処置のための薬学的調製物
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
US9254294B2 (en) 2003-02-24 2016-02-09 Pharmaceutical Productions Inc. Transmucosal hormone delivery system
US9498454B2 (en) 2003-02-24 2016-11-22 Pharmaceutical Productions Inc. Transmucosal drug delivery system
US9358296B2 (en) 2003-02-24 2016-06-07 Pharmaceutical Productions Inc. Transmucosal drug delivery system
DK1667678T3 (da) 2003-10-03 2009-08-24 Veijlen N V Dyrefodersammensætning
JP4641942B2 (ja) 2003-10-03 2011-03-02 フェーイレン・ナムローゼ・フェンノートシャップ ヒトおよび動物におけるｉｇｆ−１血清レベルの低下と関連した種々の疾患状態の治療用の治療用組成物の製造のための血清中ｉｇｆ−１レベルを増加できる化合物の使用
KR100776294B1 (ko) * 2006-08-30 2007-11-16 엘지전자 주식회사 냉장고
KR100835183B1 (ko) * 2006-08-30 2008-06-04 엘지전자 주식회사 냉장고
CN101516255A (zh) * 2006-09-13 2009-08-26 皇家飞利浦电子股份有限公司 用于自动调整褪黑素的剂量和/或递送褪黑素的装置
ES2575549T3 (es) * 2007-04-11 2016-06-29 John A. Mccarty Comprimido de melatonina y métodos de preparación y uso
UY33103A (es) 2009-12-15 2011-07-29 Techsphere S A De C V Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
KR102262306B1 (ko) 2013-07-04 2021-06-09 (주)아모레퍼시픽 월경 전기 증후군 및 월경통 완화의 기능을 갖는 조성물
KR102192573B1 (ko) 2020-08-12 2020-12-18 문종진 생리통 및 피부 트러블의 예방 및 개선용 조성물
CN113876689A (zh) * 2021-11-01 2022-01-04 冷静 一种改进型褪黑素的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2967049D1 (en) * 1978-04-11 1984-07-19 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4600723A (en) * 1983-05-18 1986-07-15 Monash University Method for minimizing disturbances in circadian rhythms of bodily performance and function
DE3466215D1 (en) * 1983-05-18 1987-10-22 Univ Monash The use of melatonin for the manufacture of a medicament
US4687763A (en) * 1985-02-25 1987-08-18 Massachusetts Institute Of Technology Composition and method for increasing levels or release of brain serotonin
US4746674A (en) * 1985-08-27 1988-05-24 Cellena (Cell Engineering) Ag Melatonin compositions and uses thereof
US4654361A (en) * 1986-01-27 1987-03-31 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Method of lowering intraocular pressure using melatonin
NZ215767A (en) * 1986-04-09 1989-10-27 Nz Government Stimulating cashmere fibre growth on cashmere-producing goats by administration of melatonin
US4855305A (en) * 1987-03-23 1989-08-08 Applied Medical Research Compositions and methods of effecting contraception utilizing melatonin
EP0311651A1 (de) * 1987-04-01 1989-04-19 Cellena (Cell Engeneering) A.G. Melatonin-derivate gegen psychogenen stress und akute angstzustände und immunstimulierende medikamente

Also Published As

Publication number Publication date
US4945103A (en) 1990-07-31
CA2075904A1 (en) 1991-08-10
EP0514373B1 (de) 1995-06-28
CA2075904C (en) 2004-07-20
AU5192890A (en) 1991-09-03
EP0514373A1 (de) 1992-11-25
DE69020582D1 (de) 1995-08-03
DE69020582T2 (de) 1996-01-04
ES2074565T3 (es) 1995-09-16
IL93053A (en) 1994-02-27
AU642864B2 (en) 1993-11-04
ATE124260T1 (de) 1995-07-15
WO1991012007A1 (en) 1991-08-22
EP0514373A4 (en) 1993-03-17
KR920700649A (ko) 1992-08-10
KR0171408B1 (ko) 1999-02-01

Similar Documents

Publication Publication Date Title
EG19304A (en) Method of treating pre-menstrual syndrome
HU9202072D0 (en) An improved method for treatment of autoimmunic diseases by means of introduction of autoantigenes in form of aerosol
GB2190842B (en) Apparatus for the cryogenic treatment of the skin
GB2227103B (en) Laser apparatus for medical treatment
EP0552256A4 (de)
EP0553291A4 (en) Treatment of autoimmune diseases by oral administration of autoantigens
EP0460912A3 (en) Medicaments for the treatment of sexual disorder
DE3683586D1 (de) Behandlung des atemunwohlseinsyndroms bei erwachsenen.
HU883863D0 (en) Process for the preparation of producing and/or portionly form of therapeutical agents
DE69027311D1 (en) Neue chroman- und thiochromanderivate
OA09908A (en) Treatment of neoplastic disease with interleukin-10
DE3478749D1 (en) Covalently bound heparin - antithrombin-iii complex, method for its preparation and its use for treating thromboembolism
PL285854A1 (en) Therapeutical device, especially for treatment of sexual disorders in men
PT92866A (pt) Metodo para o tratamento de sindroma pre-menstrual, utilizando melatonina
EP0904094A4 (de) Behandlung von knochenleiden mit adrenomedullin
ES2117008T3 (es) Metodo de tratamiento con amperozida de la esquizofrenia resistente a la terapia.
EP0458537A3 (en) Therapeutic compound for the treatment of bronchitis
DE3377650D1 (en) Hydantoin therapeutic agents
GR880100613A (en) Medical device for gums treatment
HUT37030A (en) Therapeutic auxiliary device for the treatment of traumatological patients, first of all with lower limb fraction
KR920009403A (ko) 수면장해 치료용 이미다조벤조디아제핀
MX9700626A (es) USO DE AZASPIRANOS EN LA REPARACIaN DE COMPOSICIONES PARA TRATAR INFECCIONES OPORTUNISTAS.
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
PL268278A1 (en) Apparatus for narrowing an invalid's wheel chair
ES2011526A6 (es) Instalacion para la regeneracion y depouracion de la sangre.